Marie Maerevoet Selected Research

Marie Maerevoet Research Topics

8	Neoplasms (Cancer) 01/2022 - 02/2007
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022 - 07/2020
3	Lymphoma (Lymphomas) 01/2022 - 04/2014
2	Hodgkin Disease (Hodgkin's Disease) 02/2022 - 06/2018
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 04/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2018 - 02/2007
2	Hematologic Neoplasms (Hematological Malignancy) 11/2017 - 09/2015
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2017 - 11/2005
2	Breast Neoplasms (Breast Cancer) 04/2011 - 12/2009
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022
1	Disease Progression 07/2020
1	Pure Red-Cell Aplasia 01/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019
1	Febrile Neutropenia 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Pancytopenia 01/2019
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2019
1	Neutropenia 01/2019
1	Cytopenia 01/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2018
1	Fatigue 11/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2017
1	Pathologic Complete Response 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2009
1	B-Cell Leukemia (Leukemia, B Cell) 02/2007
1	Osteonecrosis (Kienbock's Disease) 07/2005

6	selinexorIBA 02/2022 - 07/2020
2	Brentuximab VedotinIBA 02/2022 - 06/2018
2	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2019
2	obinutuzumabIBA 01/2022 - 01/2019
2	Monoclonal AntibodiesIBA 01/2022 - 11/2017
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 04/2011
2	Rituximab (Mabthera)FDA Link 04/2014 - 11/2005
2	AnthracyclinesIBA 04/2011 - 12/2009
1	pembrolizumabIBA 02/2022
1	Heme (Haem)IBA 01/2019
1	LigandsIBA 01/2019
1	AntibodiesIBA 01/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2018
1	insulin receptor-related receptor (IRR)IBA 11/2017
1	Cyclin D1IBA 06/2017
1	Epirubicin (Ellence)FDA LinkGeneric 04/2011
1	Estrogen ReceptorsIBA 04/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2011
1	Docetaxel (Taxotere)FDA Link 12/2009
1	Trastuzumab (Herceptin)FDA Link 12/2009
1	human ERBB2 proteinIBA 12/2009
1	Hormones (Hormone)IBA 12/2009
1	purineIBA 02/2007
1	Cladribine FDA LinkGeneric 02/2007
1	Mitogen-Activated Protein KinasesIBA 02/2007
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2007
1	Chlorambucil (Leukeran)FDA Link 11/2005
1	Diphosphonates (Bisphosphonates)IBA 07/2005

8	Therapeutics 01/2022 - 11/2005
5	Drug Therapy (Chemotherapy) 02/2022 - 12/2009
3	Stem Cell Transplantation 02/2022 - 06/2018
2	Radiotherapy 01/2017 - 12/2009
1	Immunotherapy 01/2019
1	Breast Implants (Breast Implant) 10/2018
1	Duration of Therapy 11/2017
1	Adjuvant Chemotherapy 12/2009